Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Clinical management of hereditary breast cancer syndromes.

Clark AS, Domchek SM.

J Mammary Gland Biol Neoplasia. 2011 Apr;16(1):17-25. doi: 10.1007/s10911-011-9200-x. Epub 2011 Mar 1. Review.

PMID:
21360002
[PubMed - indexed for MEDLINE]
2.

Breast cancer and ovarian cancer genetics.

Edlich RF, Winters KL, Lin KY.

J Long Term Eff Med Implants. 2005;15(5):533-45. Review.

PMID:
16218901
[PubMed - indexed for MEDLINE]
3.

Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.

Casey MJ, Synder C, Bewtra C, Narod SA, Watson P, Lynch HT.

Gynecol Oncol. 2005 May;97(2):457-67.

PMID:
15863145
[PubMed - indexed for MEDLINE]
4.

Therapeutic approaches for women predisposed to breast cancer.

Nathanson KL, Domchek SM.

Annu Rev Med. 2011;62:295-306. doi: 10.1146/annurev-med-010910-110221. Review.

PMID:
21034216
[PubMed - indexed for MEDLINE]
5.

Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.

Kuschel B, Lux MP, Goecke TO, Beckmann MW.

Eur J Cancer Prev. 2000 Jun;9(3):139-50. Review.

PMID:
10954253
[PubMed - indexed for MEDLINE]
6.

The problems with risk selection; scientific and psychosocial aspects.

Hartman AR.

Recent Results Cancer Res. 2005;166:125-44. Review.

PMID:
15648188
[PubMed - indexed for MEDLINE]
7.

[Hereditary breast and ovarian cancer: primary and secondary prevention for BRCA1 and BRCA2 mutation carriers].

Llort G, Peris M, Blanco I.

Med Clin (Barc). 2007 Mar 31;128(12):468-76. Review. Spanish.

PMID:
17408542
[PubMed - indexed for MEDLINE]
8.

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.

Warner E, Plewes DB, Hill KA, Causer PA, Zubovits JT, Jong RA, Cutrara MR, DeBoer G, Yaffe MJ, Messner SJ, Meschino WS, Piron CA, Narod SA.

JAMA. 2004 Sep 15;292(11):1317-25.

PMID:
15367553
[PubMed - indexed for MEDLINE]
9.

BRCA mutations in the management of breast cancer: the state of the art.

Narod SA.

Nat Rev Clin Oncol. 2010 Dec;7(12):702-7. doi: 10.1038/nrclinonc.2010.166. Epub 2010 Oct 19. Review.

PMID:
20956982
[PubMed - indexed for MEDLINE]
10.

Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.

Roukos DH, Briasoulis E.

Nat Clin Pract Oncol. 2007 Oct;4(10):578-90. Review.

PMID:
17898808
[PubMed - indexed for MEDLINE]
11.

Hereditary breast-ovarian cancer: clinical findings and medical management.

Marshall M, Solomon S.

Plast Surg Nurs. 2007 Jul-Sep;27(3):124-7. Review.

PMID:
17901820
[PubMed - indexed for MEDLINE]
12.

Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature.

Calderon-Margalit R, Paltiel O.

Int J Cancer. 2004 Nov 10;112(3):357-64. Review.

PMID:
15382059
[PubMed - indexed for MEDLINE]
13.

MRI in the early detection of breast cancer in women with high genetic risk.

Trecate G, Vergnaghi D, Manoukian S, Bergonzi S, Scaperrotta G, Marchesini M, Ferranti C, Peissel B, Spatti G, Bohm S, Conti A, Costa C, Sporeni M, Podo F, Musumeci R.

Tumori. 2006 Nov-Dec;92(6):517-23.

PMID:
17260493
[PubMed - indexed for MEDLINE]
14.

Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population.

Meindl A; German Consortium for Hereditary Breast and Ovarian Cancer.

Int J Cancer. 2002 Feb 1;97(4):472-80.

PMID:
11802209
[PubMed - indexed for MEDLINE]
15.

Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing.

de la Hoya M, Osorio A, Godino J, Sulleiro S, Tosar A, Perez-Segura P, Fernandez C, Rodríguez R, Díaz-Rubio E, Benítez J, Devilee P, Caldés T.

Int J Cancer. 2002 Feb 1;97(4):466-71.

PMID:
11802208
[PubMed - indexed for MEDLINE]
16.

Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing.

Botkin JR, Smith KR, Croyle RT, Baty BJ, Wylie JE, Dutson D, Chan A, Hamann HA, Lerman C, McDonald J, Venne V, Ward JH, Lyon E.

Am J Med Genet A. 2003 Apr 30;118A(3):201-9.

PMID:
12673648
[PubMed - indexed for MEDLINE]
17.

Breast cancer predisposition syndromes.

Hemel D, Domchek SM.

Hematol Oncol Clin North Am. 2010 Oct;24(5):799-814. doi: 10.1016/j.hoc.2010.06.004. Review.

PMID:
20816575
[PubMed - indexed for MEDLINE]
18.

ACOG Practice Bulletin No. 103: Hereditary breast and ovarian cancer syndrome.

American College of Obstetricians and Gynecologists; ACOG Committee on Practice Bulletins--Gynecology; ACOG Committee on Genetics; Society of Gynecologic Oncologists.

Obstet Gynecol. 2009 Apr;113(4):957-66. doi: 10.1097/AOG.0b013e3181a106d4.

PMID:
19305347
[PubMed - indexed for MEDLINE]
19.

Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families.

Krajc M, Teugels E, Zgajnar J, Goelen G, Besic N, Novakovic S, Hocevar M, De Grève J.

BMC Med Genet. 2008 Sep 10;9:83. doi: 10.1186/1471-2350-9-83.

PMID:
18783588
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk